1. Home
  2. CMCM vs CRBP Comparison

CMCM vs CRBP Comparison

Compare CMCM & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheetah Mobile Inc. each representing fifty (50)

CMCM

Cheetah Mobile Inc. each representing fifty (50)

N/A

Current Price

$7.38

Market Cap

188.7M

Sector

Technology

ML Signal

N/A

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

N/A

Current Price

$9.56

Market Cap

134.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMCM
CRBP
Founded
2009
2009
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.7M
134.8M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
CMCM
CRBP
Price
$7.38
$9.56
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$46.17
AVG Volume (30 Days)
14.4K
152.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
64.31
EPS
N/A
N/A
Revenue
N/A
$4,822,272.00
Revenue This Year
$14.27
N/A
Revenue Next Year
$39.26
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
97.62
52 Week Low
$3.28
$4.64
52 Week High
$9.44
$20.56

Technical Indicators

Market Signals
Indicator
CMCM
CRBP
Relative Strength Index (RSI) 68.63 67.05
Support Level $6.95 $8.68
Resistance Level $7.80 $9.69
Average True Range (ATR) 0.39 0.55
MACD 0.22 0.17
Stochastic Oscillator 83.47 96.90

Price Performance

Historical Comparison
CMCM
CRBP

About CMCM Cheetah Mobile Inc. each representing fifty (50)

Cheetah Mobile Inc along with its subsidiaries provides comprehensive products and services on PCs and mobile devices. It generates revenue from utility-related business, including advertising services and premium membership services. It also provides multi-cloud management platform and overseas advertising agency service. The company operates in two segments: Internet business, and AI and others. The firm's majority of the revenue is derived from the internet business segment that provides mobile advertising services to advertising customers, as well as selling advertisements and referring user traffic on its mobile and PC platforms. Geographically, it derives the majority of its revenue from the PRC and the rest from Hong Kong, Japan, and the rest of the world.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: